Keywords: میاستنی گراویس; Myasthenia gravis; Health-related quality of life; Anxiety; Depression; Muscle weakness;
مقالات ISI میاستنی گراویس (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: میاستنی گراویس; Arthritis; disease-modifying antirheumatics; gout; immunosuppressants; joint disease; muscle disease; myasthenia gravis; NSAIDs;
Keywords: میاستنی گراویس; 3,4-Diaminopyridine; Treatment; Anti-acetylcholine receptor antibody; Myasthenia gravis; Lambert-Eaton myasthenic syndrome;
Keywords: میاستنی گراویس; Myasthenia gravis; Ocular vestibular evoked myogenic potential; Otolith; Utricular function;
Keywords: میاستنی گراویس; Thyrotoxicosis; Myasthenia gravis; Ophthalmoplgia; Goitre;
Keywords: میاستنی گراویس; Myasthenia gravis; Acetylcholine receptor; Antimuscle-specific kinase; Occular;
Keywords: میاستنی گراویس; Neuromuscular disease (NMD); Dysphagia; Sialorrhea; Amyotrophic lateral sclerosis; Muscular dystrophy; Myasthenia gravis;
Keywords: میاستنی گراویس; Pregnancy; Myasthenia gravis; Neonatal myasthenia gravis; Arthrogryposis;
Keywords: میاستنی گراویس; Myasthenia gravis; West Nile virus; Neuroinvasive disease; Autoimmunity; Myasthenic crisis; Post-infectious; Inflammation;
Keywords: میاستنی گراویس; Myasthenia gravis; Thymectomy; VATS; Sternotomy;
Keywords: میاستنی گراویس; Myasthenia gravis; Systemic lupus erythematosus; Acetylcholine receptor antibody; Antinuclear antibody; Antiphospholipid antibody; Thymectomy; AChR; Acetylcholine receptor; anti-AChR antibody; Anti-acetylcholine receptor antibody; ANA; Antinuclear antibod
Keywords: میاستنی گراویس; Myasthenia Gravis; Characteristics; Mortality; Critical care outcome; Australia and New Zealand;
Keywords: میاستنی گراویس; myasthenia gravis; thymoma; thymectomy; acetylcholine receptor antibodies;
Keywords: میاستنی گراویس; Diaphragmatic dysfunction; Neuromuscular disease; Phrenic neuropathy; Myasthenia gravis; Myopathy;
Keywords: میاستنی گراویس; Myasthenia gravis; Autoantibodies; Diagnosis; Immunosticks; Acetylcholine receptor; ELISA; MuSK; AChR; acetylcholine receptor; LRP4; low-density lipoprotein receptor-related protein 4; MG; myasthenia gravis; MuSK; muscle specific kinase; RIPA; radioimmuno
Keywords: میاستنی گراویس; Costs; Long-term outcome; Monoclonal antibody; Myasthenia gravis; Pregnancy; Rituximab; Safety; Treatment;
Keywords: میاستنی گراویس; Anaesthesia; botulism; Guillain-Barré; motor neurone disease; muscular dystrophy; myasthenia gravis; neuromuscular disease; neuromuscular junction;
Keywords: میاستنی گراویس; Myotonic dystrophy; Myasthenia gravis; Graves' disease; Hypocretin;
Keywords: میاستنی گراویس; Abs; antibodies; AchR; muscle acetylcholine receptor; IVIg; intravenous immunoglobulin; MG; myasthenia gravis; MGFA-PIS; myasthenia gravis foundation of America-post interventional status; MGCS; myasthenia gravis composite scale; MuSK; muscle-specific tyr
Keywords: میاستنی گراویس; Myasthenia gravis; Prevalence; Neuroepidemiology; Immunosenescence; Ageing; Geriatric neurology; Miastenia gravis; Prevalencia; NeuroepidemiologÃa; Senescencia inmunológica; Edad avanzada; NeurogeriatrÃa;
Keywords: میاستنی گراویس; Myasthenia gravis; IVIg; Pregnancy; Monotherapy; Treatment; Delivery; Transient neonatal myasthenia; IVIg; intravenous immunoglobulins; MG; myasthenia gravis; QMG; quantitative myasthenia gravis;
Keywords: میاستنی گراویس; MG; myasthenia gravis; MGFA; Myasthenia Gravis Foundation of America; CSR; complete stable remission; PR; pharmacologic remission; MM; minimal manifestations; IM; improvement; VATS; video-assisted thoracoscopic surgery; OMG; ocular form MG; GMG; generaliz
Keywords: میاستنی گراویس; Myasthenia gravis; Obesity; Adipokines; Body composition; Dual-energy X-ray absorptiometry;
Keywords: میاستنی گراویس; Myasthenia gravis; Receptors, cholinergic; Autoantibodies; Cytokines; Neuromuscular junction; Jianpiyiqi granule;
Keywords: میاستنی گراویس; Blood component removal; Myasthenia gravis; Botulinum toxins;
Keywords: میاستنی گراویس; Myasthenia gravis; MG-QOL 15; Validation; Quality of life; Questionnarie;
Keywords: میاستنی گراویس; Parkinson's disease; Head drop; Anterocollis; Myasthenia gravis; Inclusion body myositis; Myopathy;
Keywords: میاستنی گراویس; Inmunoglobulina; Intravenosa/endovenosa; Sistema nervioso periférico; SÃndrome de persona rÃgida; NeuropatÃas agudas; NeuropatÃas crónicas; MiopatÃas; Miastenia grave; NeuropatÃas por paraproteinemias; GanglionopatÃas; NeuropatÃas de fibras fina
Keywords: میاستنی گراویس; Myasthenia gravis; Speech acoustics; PRAAT; Phonation; Voice; Electroglottography;
Keywords: میاستنی گراویس; Myasthenia gravis; MG; Tacrolimus; Prednisolone; MGCS; ADR;
Keywords: میاستنی گراویس; Systemic lupus erythematosus; Myasthenia gravis; Autoimmunity; Neurologic disorder; Acetylcholine receptor antibody;
Keywords: میاستنی گراویس; Myasthenia gravis; Muscle fatigue; Staircase phenomenon; Excitation-contraction coupling; Post-tetanic potentiation;
Keywords: میاستنی گراویس; Myasthenia gravis; Therapeutic plasma exchange; Plasmapheresis; Quality of life; Questionnaire SF-36;
Keywords: میاستنی گراویس; MMP-3; matrix metalloproteinase-3; EEG; electroencephalogram; ELISAs; enzyme-linked immunosorbent assays; AED; anti-epileptic drug; ROC; Receiver Operator Characteristic; MG; Myasthenia gravis; Epilepsy; Serum; Metalloproteinase; Biomarker;
Keywords: میاستنی گراویس; Myasthenia gravis; Muscle weakness; Pain; Synapses; Acetylcholine;
Keywords: میاستنی گراویس; MG; myasthenia gravis; EBV; Epstein-Barr virus; TLR; Toll-like receptor; GC; germinal center; IFN; interferon; AChR; acetylcholine receptor; EBER; EBV-encoded small RNA; LCM; laser-capture microdissection; IRF8; interferon regulatory factor 8; LMP1; Eps
Keywords: میاستنی گراویس; Neuromuscular disease; Neuromuscular junction disorder; Motor neuron disease; Amyotrophic lateral sclerosis; Myasthenia gravis; Spinal cord disorders; Phrenic nerve damage; Myotonic dystrophy;
Keywords: میاستنی گراویس; Acute weakness; Guillain-Barre syndrome; Myasthenia gravis; Periodic paralysis; Transverse myelitis; Tick paralysis; Botulism;
Keywords: میاستنی گراویس; Neuromuscular diseases; Acute inflammatory demyelinating polyneuropathy; Guillain-Barre syndrome; Amyotrophic lateral sclerosis; Myasthenia gravis; Critical illness polyneuropathy; Critical illness myopathy;
Keywords: میاستنی گراویس; BTX; bungarotoxin; CME; clathrin-mediated endocytosis; ER stress; endoplasmic reticulum stress; ERAD; endoplasmic reticulum-associated degradation; MβCD; methyl-beta-cyclodextrin; MFI; mean fluorescence intensity; AChR; acetylcholine receptor; ATF6; acti
Keywords: میاستنی گراویس; MG; myasthenia gravis; AChR; acetylcholine receptor; MuSK; muscle specific kinase; EAMG; experimentally acquired myasthenia gravis; PTMG; passive transfer myasthenia gravis; Myasthenia gravis; Clinical trials; Therapeutic development; Preclinical assessme
Keywords: میاستنی گراویس; MG; myasthenia gravis; AChR; nicotinic acetylcholine receptor; ECD; extracellular domain; MIR; main immunogenic region; AChBP; acetylcholine binding protein; α-Btx; α-bungarotoxin.; Nicotinic acetylcholine receptor; Extracellular domain; Myasthenia grav
Keywords: میاستنی گراویس; Neuromuscular junction; Myasthenia gravis; Lambert-Eaton myasthenic syndrome; Botulism; Organophosphate poisoning; Congenital myasthenic syndrome;
Keywords: میاستنی گراویس; AID; autoimmune disorders; AF; adjuvant formulations; ASIA; autoimmune/inflammatory syndrome induced by adjuvants; CFA; complete Freundâ²s adjuvant; CIA; collagen-induced arthritis; DA; dark Agouti; DC; dendritic cells; EAE; experimental autoimmune encep
Keywords: میاستنی گراویس; Morvan chorea; Status dissociatus; Agrypnia excitata; Anti-CASPR2 antibodies; Myasthenia gravis; Sodium oxybate;
Keywords: میاستنی گراویس; AChR; acetylcholine receptor; AChR-Ab; acetylcholine receptor antibody; AIRE; autoimmune regulator; APECED; autoimmune polyendocriopathy candidiasis ectodermal dystrophy; APS-I; autoimmune polyendocrine syndrome type-I; EOMG; early onset Myasthenia gravis
Keywords: میاستنی گراویس; Cytokines; Double-filtration plasmapheresis; Myasthenia gravis; Regulatory T cells; Titin-antibody;
Keywords: میاستنی گراویس; Lymphoma; Leukemia; Myasthenia gravis; Thymus cancer; Thymic carcinoma;
Keywords: میاستنی گراویس; Myasthenia gravis; Extrathymic malignancies; Thymoma; Risk factors; Therapy;
Keywords: میاستنی گراویس; Thymic carcinoma; Thymus; Masaoka staging system; Myasthenia Gravis; Surgery; Outcome;